Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers.
Jessica Germaine ShullMaria Teresa PayCarla Lara CompteMiriam OlidGuadalupe BermudoKarina PortilloJacobo SellarésEva BalcellsVanesa Vicens-ZygmuntLurdes Planas-CerezalesDiana Badenes-BonetRosana BlaviaPilar Rivera-OrtegaAmalia MorenoJordi SansDamià PerichSilvia BarrilLeonardo EstebanLaia Garcia-BellmuntJordi EsplugasGuillermo Suarez-QuartinJaume Bordas-MartinezDiego CastilloRosa JolisInma SalvadorSaioa Eizaguirre AntonAna VillarAlejandro Robles-PerezM Josefa CardonaEnric BarbetaMaria Guadalupe SilveiraClaudia GuevaraJordi DorcaAntoni RosellPatricio LuburichRoger LlatjósOriol JorbaMaria Molina-MolinaPublished in: Respirology (Carlton, Vic.) (2020)
In this retrospective study, prevalence of IPF is higher in areas of elevated PM2.5 concentration. Prospective studies with targeted pollution mapping need to be done in specific geographies to compile a broader profile of environmental factors involved in the development of pulmonary fibrosis.